Sharon Malia, PhD, is Vice President, Quality, at Aura where she is responsible for leading the Quality Organization inclusive of Manufacturing Quality Assurance, Clinical Quality Assurance, Quality Control, and Quality Systems. Dr. Malia joins Aura from Viotech Consulting, where she provided senior-level quality gap assessments and buildout for early- and late-stage clinical programs. Prior to Viotech, Dr. Malia served as Senior Director, Quality Control and Stability for Allena Pharmaceuticals where she directed the QC and Stability functions for drug substance, drug product and finished drug product for programs in various phases of clinical development. Prior to Allena, Dr. Malia held positions of increasing responsibility at several biotech companies including LFB USA, Olympus Biotech Corporation, Toxikon Corporation, and Advanced Viral Research where she was responsible for quality, stability and method development. Dr. Malia holds a Ph.D. and M.S. in chemistry from the University of Connecticut and completed her postdoctoral research at Massachusetts Institute of Technology.